Phillip Pang, Chief Medical Officer at Vir Biotechnology, Inc. (VIR), sold 4,000 shares at $39.65 ($159K) on 2021-10-20, disclosed to the SEC on 2021-10-22.
Open-market sale of $159k VIR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VIR | SELL | 2023-06-08 | $130K | — | Filing → |
| VIR | SELL | 2023-02-28 | $238K | — | Filing → |
| VIR | SELL | 2023-02-24 | $149K | — | Filing → |